Christopher Pittenger

21.6k total citations · 1 hit paper
161 papers, 10.3k citations indexed

About

Christopher Pittenger is a scholar working on Clinical Psychology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher Pittenger has authored 161 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Clinical Psychology, 75 papers in Cognitive Neuroscience and 48 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher Pittenger's work include Obsessive-Compulsive Spectrum Disorders (94 papers), Autism Spectrum Disorder Research (36 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (34 papers). Christopher Pittenger is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (94 papers), Autism Spectrum Disorder Research (36 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (34 papers). Christopher Pittenger collaborates with scholars based in United States, Japan and Australia. Christopher Pittenger's co-authors include Ronald S. Duman, Michael H. Bloch, Eric R. Kandel, James F. Leckman, John H. Krystal, Luciana Romina Frick, Angeli Landeros‐Weisenberger, Vladimir Coric, Patricia Gruner and Gerard Sanacora and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Christopher Pittenger

150 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

2007 1.4k citations Christopher Pittenger et al. Neuropsychopharmacology profile →

Peers

Countries citing papers authored by Christopher Pittenger

Since Specialization

Citations

This map shows the geographic impact of Christopher Pittenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pittenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pittenger more than expected).

Fields of papers citing papers by Christopher Pittenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Pittenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pittenger. The network helps show where Christopher Pittenger may publish in the future.

Co-authorship network of co-authors of Christopher Pittenger

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Pittenger. A scholar is included among the top collaborators of Christopher Pittenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Pittenger. Christopher Pittenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How to Probe Dynamics of Brain Function: A Narrative Review 2025 ·Biological Psychiatry ·Helen Pushkarskaya, Smita Krishnaswamy, Christopher Pittenger	0
2	Sex differences in the distribution and density of regulatory interneurons in the striatum 2024 ·Frontiers in Cellular Neuroscience ·(unknown), (unknown), Christopher Pittenger	2
3	Mechanisms of therapeutic change after psychedelic treatment in OCD 2024 ·Psychiatry Research ·(unknown), Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi	2
4	The Pharmacological Treatment of Obsessive-Compulsive Disorder 2023 ·Psychiatric Clinics of North America ·Christopher Pittenger	6
5	Neuroinflammation in Obsessive-Compulsive Disorder 2023 ·Psychiatric Clinics of North America ·Allison Vreeland, Margo Thienemann, Madeleine W. Cunningham, Eyal Muscal, Christopher Pittenger, Jennifer Frankovich	8
6	5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice 2023 ·Neuropsychopharmacology ·Sarah J. Jefferson, Ian Gregg, (unknown), Clara Liao, Hao Wu, Pasha A. Davoudian, Samuel C. Woodburn, (unknown), Jeffrey Sprouse, Alexander M. Sherwood, Alfred P. Kaye, Christopher Pittenger, Alex C. Kwan	34
7	Frontopolar multifocal transcranial direct current stimulation reduces conditioned fear reactivity during extinction training: A pilot randomized controlled trial 2023 ·Neurobiology of Learning and Memory ·Thomas G. Adams, Benjamin Kelmendi, Jamilah R. George, (unknown), (unknown), (unknown), (unknown), Christopher Pittenger	1
8	Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity 2023 ·Frontiers in Psychiatry ·Jennifer Warner‐Schmidt, Christopher Pittenger, Martin Stogniew, (unknown), (unknown), Benjamin Kelmendi	8
9	Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive‐compulsive disorder: Results from two pilot studies 2021 ·Depression and Anxiety ·Thomas G. Adams, Josh M. Cisler, Benjamin Kelmendi, Jamilah R. George, Stephen A. Kichuk, Christopher L. Averill, Alan Anticevic, Chadi G. Abdallah, Christopher Pittenger	29
10	Pharmacological antagonism of histamine H2R ameliorated L-DOPA–induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD 2019 ·Neurobiology of Aging ·M. Rafiuddin Ahmed, (unknown), (unknown), Alsu I. Zamaleeva, Juan Tao, (unknown), (unknown), Christopher Pittenger, Hiroshi Ohtsu, Jayakumar Rajadas	14
11	Striatal Signaling Regulated by the H3R Histamine Receptor in a Mouse Model of tic Pathophysiology 2018 ·Neuroscience ·Maximiliano Rapanelli, Luciana Romina Frick, (unknown), Jian Xu, Hiroshi Ohtsu, Angus C. Nairn, Christopher Pittenger	11
12	Modeling tics in rodents: Conceptual challenges and paths forward 2017 ·Journal of Neuroscience Methods ·Marco Bortolato, Christopher Pittenger	23
13	Randomized, Double-Blind, Placebo-Controlled Trial of <em>N</em>-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder 2017 ·The Journal of Clinical Psychiatry ·Daniel L. Costa, Juliana Belo Diniz, (unknown), (unknown), Christopher Pittenger, Michael H. Bloch, Eurı́pedes Constantino Miguel, Roseli Gedanke Shavitt	67
14	Targeted Interneuron Depletion in the Dorsal Striatum Produces Autism-like Behavioral Abnormalities in Male but Not Female Mice 2017 ·Biological Psychiatry ·Maximiliano Rapanelli, Luciana Romina Frick, Meiyu Xu, Stephanie M. Groman, (unknown), Nobuaki Tamamaki, (unknown), Jane R. Taylor, Christopher Pittenger	64
15	Cognitive inflexibility in Obsessive-Compulsive Disorder 2016 ·Neuroscience ·Patricia Gruner, Christopher Pittenger	170
16	Glutamatergic agents for OCD and related disorders 2015 ·Current Treatment Options in Psychiatry ·Christopher Pittenger	39
17	Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder 2015 ·The Journal of Clinical Psychiatry ·Christopher Pittenger, Michael H. Bloch, Suzanne Wasylink, Eileen Billingslea, (unknown), Ewgeni Jakubovski, Ben Kelmendi, Gerard Sanacora, Vladimir Coric	57
18	Symptom dimensions are associated with age of onset and clinical course of obsessive–compulsive disorder 2013 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Stephen A. Kichuk, Albina Rodrigues Torres, Leonardo F. Fontenelle, Maria Conceição do Rosário, Roseli Gedanke Shavitt, Eurı́pedes Constantino Miguel, Christopher Pittenger, Michael H. Bloch	37
19	Glutamatergic dysfunction in obsessive-compulsive disorder and the potential clinical utility of glutamate-modulating agents 2006 ·Christopher Pittenger, Michael H. Bloch, Ryan Wegner, (unknown), John H. Krystal, Vladimir Coric	11
20	Some Forms of cAMP-Mediated Long-Lasting Potentiation Are Associated with Release of BDNF and Nuclear Translocation of Phospho-MAP Kinase 2001 ·Neuron ·Susan L. Patterson, Christopher Pittenger, Alexei Morozov, Kelsey C. Martin, (unknown), Carrie T. Drake, Eric R. Kandel	273

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact